| [1] Ziemssen T, Reichmann H. Non-motor dysfunction in Parkinson's disease[J]. Parkinsonism Relat Disord, 2007,13(6):323-332.[2] Qian L, Flood P M, Hong J S. Neuroinflammation is a key player in Parkinson disease and a prime target for therapy[J]. J Neural Transm, 2010,117(8):971-979.[3] Shiratsuch H, Basson M D. Differential regulation of monocyte/macrophage cytokine production by pressure[J]. Am J Surg, 2005,190(5):757-762.[4] Liu B, Du L, Hong J S. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation[J]. J Pharmacol Exp Ther, 2000,293(2):607-617.[5] Herrera A J, Castaño A, Venero J L, et al. The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system[J]. Neurobiol Dis, 2000,7(4):429-447.[6] Fumagalli F, Gainetdinov R R, Valenzano K J, et al. Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter[J]. J Neurosci, 1998,18(13):4861-4869.[7] Finkel Y, Eklof A C, Granquist L, et al. Endogenous dopamine modulates jejunal sodium absorption during high-salt diet in young but not in adult rats[J]. Gastroenterolo, 1994,107(3):675-679.[8] Zhang X H, Zhang X F, Zhang J Q, et al. β-adrenoceptors, but not dopamine receptors, mediate dopamine-induced ion transport in late distal colon of rats[J]. Cell Tissue Res, 2008,334(1):25-35.[9] Zhang X H, Guo H, Xu J D, et al. Dopamine receptor D1 mediates the inhibition of dopamine on the distal colonic motility[J]. Transl Res, 2012,159(5):407-414.[10] Haskel Y, Hanani M. Inhibition of gastrointestinal motility by MPTP via adrenergic and dopaminergic mechanisms[J]. Dig Dis Sci, 1994,39(11):2364-2367.[11] 米新亮,李蕴,郭华,等.5-HT3/4受体在内源性多巴胺调节胃动力中的作用[J].首都医科大学学报,2010,31(2):217-221.[12] Szabo S. Dopamine disorder in duodenal ulceration[J]. Lancet, 1979,2(8148):880-882.[13] Vucetic Z, Reyes T M. Central dopaminergic circuitry controlling food intake and reward: implications for the regulation of obesity[J]. Wiley Interdiscip Rev Syst Biol Med, 2010,2(5):577-593.[14] Hayakawa T, Takanaga A, Tanaka K, et al. Distribution and ultrastructure of dopaminergic neurons in the dorsal motor nucleus of the vagus projecting to the stomach of the rat[J]. Brain Res, 2004,1006(1):66-73.[15] Zheng Z, Travagli R A. Dopamine effects on identified rat vagal motoneurons[J]. Am J Physiol Gastrointest Liver Physiol, 2007,292(4):G1002-G1008.[16] Zheng L F, Wang Z Y, Li X F, et al. Reduced expression of choline acetyltransferase in vagal motoneurons and gastric motor dysfunction in a 6-OHDA rat model of Parkinson's disease[J]. Brain Res, 2011,1420: 59-67.[17] Cai Q Q, Zheng L F, Fan R F, et al. Distribution of dopamine receptors D1- and D2-inmunoreactive neurons in the dorsal motor nucleus of vagus in rats[J]. Auton Neurosci, 2013,176(1-2):48-53.[18] Phillips R J, Walter G C, Wilder S L, et al. Alpha-synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: autonomic pathway implicated in Parkinson's disease?[J]. Neuroscience, 2008,153(3):733-750.[19] Braak H, Del Tredici K, Rüb U, et al. Staging of brain pathology related to sporadic Parkinson's disease[J]. Neurobiol Aging, 2003,24(2):197-211.[20] 李林,茹立强.大鼠肠道内ACh能、SP、VIP-肽能和NO能神经的分布模式及相互关系[J].华中科技大学学报:医学版,2009,38(5):575-580.[21] Takahashi T, Kurosawa S, Wiley J W, et al. Mechanism for the gastrokinetic action of domperidone In vitro studies in guinea pigs[J]. Gastroenterology, 1991,101(3):703-710.[22] Tian Y M, Chen X, Luo D Z, et al. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease[J]. Neuroscience, 2008,153(3):634-644. |
